FABP4fl/flpvillinCreT mice exhibited resistance to both DSS-mediated colitis and HFD-mediated obesity as compared to control FABP4fl/fl mice (Figure S3 and Figure S4), implying that FABP4 also affects the composition of gut microbiota. Here, FABP4 is linked to obesity disorder.